ALT-2074

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameALT-2074
Drug Alias NameALT-2074SYI-2074BXT 51072
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell adhesion molecules inhibitorsGlutathione peroxidase stimulants
TargetsCell adhesion moleculesGlutathione peroxidase
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes MellitusPsoriasis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOxis Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSynvista Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes MellitusPsoriasis +[5] 

Other Information

ATC CodeN/A
Related LinksN/A